Document is current
Any future updates will be listed below
-
Authors
Brayden, David J. https://orcid.org/0000-0002-8781-8344
-
Funding
Funding for this research was provided by:
Science Foundation Ireland (13/RC/2073_2)
- License Information
-
More Information
Article History
Accepted: 13 October 2022
First Online: 25 October 2022
Declarations
:
: DB devised and wrote the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: This publication was supported in part by a grant from Science Foundation Ireland (SFI) under Grant number 13/RC/2073_2 and with support from the European Regional Development Fund.
: DB has a current research collaboration and consultancy with Janssen. As the company was mentioned in the article in relation to their collaboration with Protagonist Ltd, this could be interpreted as a perceived conflict of interest, hence its full disclosure. Similarly, BMS was also cited, and it will be funding a postdoctoral fellowship in his lab from 2023. DB declares that he consults for Biotech and Pharma companies working on oral administration of peptides, proteins and antibodies for systemic delivery.
: The data cited in this review was from peer-reviewed literature, company websites, and was also sourced from Springer’s AdisInsight database. Source data availability can be requested from the cited authors.
